VHH Library Generation-Biointron

VHH antibody is a promising next-generation therapeutic antibody technology for cancer immunotherapy and other applications. VHH antibodies are distinguished from other conventional antibody formats by their unique properties of size, solubility, intrinsic stability, easy tailoring into pluripotent constructs, recognition of uncommon or hidden epitopes, binding into cavities or active sites of enzyme targets, ease and speed of drug discovery, and ease of manufacture.

BioIntron is a well-recognized leader in the field of single domain antibody discovery. Based on our advanced phage display technology, our scientists are specialized in the production and discovery of specific single domain antibodies.

Our Advantages

Self-owned Alpaca Breeding Farm

(more than 100 Alpacas available)

Guaranteed 20+ Unique Binders

(combined solid phase and liquid phase panning methods)

High Diversity And Large Capacity

(multiple libraries generated after 2nd, 3rd, 4th immunization)

VHH Library Generation Working Flowchart

VHH Library Generation Service Detail

Service Step	Service Description	Timeline	Price	Deliverable
Phage I: Antigen preparation /Antigen validation	Antigen can be prepared by BioIntron or provided by our client.	2 weeks for preparation / 2-3 days for validation	Inquiry	▸1mg purified protein antigen. ▸If antigen provided by client, it should be at least 4mg with SDS-PAGE >95%, endotoxin level<1EU/mg
Phage II: Alpaca immunization and PBMC isolation /preservation	▸5ml pre-immune bleed ▸the ELISA titer after 2nd ,3rd and 4th immunization will be monitored and the report will send to client ▸the 50ml PMBC after 2nd ,3rd and 4th immunization will be extracted and stored in Trizol .	8-10 weeks	Inquiry	▸Alpaca's death caused by antigen, there will be setup fee about $5,000. ▸Decision gate: based on the ELISA titer on the 2nd ,3rd and 4th immunization. Our client can decide to use which cell for library generation
Phage 3: VHH Phage Library Generation	▸RNA extraction and cDNA preparation ▸VHH amplification ▸Electro competent E. coli ▸Library Diversity and capacity measurement ▸clone NO counting and sequencing to measure the capacity of the librar	3-4 weeks	Inquiry	VHH capacity reach to 10⁹
Milestone 4: Library Biopanning and Screening	▸at least 3 round panning (both liquid phase panning and solid phase panning) ▸ELISA verification, identification and evaluation of positive clones (at 200 clones for sequencing) screening ▸positive clone sequencing and sequencing result analysis	3-4 weeks	Inquiry	Guarantee to provide at least 20 unique sequence.
VHH-Fc Antibody Production (optional)	▸Gene synthesis, subcloning, plasmid preparation ▸transient expression and purification ▸QC analysis	2 weeks	Inquiry	Purified antibody (SDS-PAGE >95%, endotoxin level <1EU/mg)
Affinity Ranking (optional)	Affinity measured by Biacore 8K	0.5 weeks	Inquiry
Note: If the ELISA titer after 4th immunization is <1:5,000, we will suggest to terminate the project and charge the fee for phase I and phase II.